* Ironwood Pharmaceuticals Inc IRWD.OQ reported quarterly
adjusted earnings of 2 cents per share for the quarter ended
September 30, lower than the same quarter last year, when the
company reported EPS of 9 cents. The mean expectation of
six analysts for the quarter was for earnings of 8 cents per
share. Wall Street expected results to range from 1 cents to 18
cents per share.
* Revenue fell 19.5% to $91.59 million from a year ago;
analysts
expected $91.25 million.
* Ironwood Pharmaceuticals Inc's reported EPS for the
quarter was
2 cents.
* The company reported quarterly net income of $3.65
million.
* Ironwood Pharmaceuticals Inc shares had risen by 13.1%
this
quarter and lost 59.3% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 0.1%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"
Wall Street's median 12-month price target for Ironwood
Pharmaceuticals Inc is 12.00
This summary was machine generated from LSEG data November 8 at
05:21 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 0.08 0.02 Missed
Jun. 30 2024 0.15 0.00 Missed
Mar. 31 2024 0.19 -0.02 Missed
Dec. 31 2023 0.21 -0.01 Missed